日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Association of Proteasome Activity and Pool Heterogeneity with Markers Determining the Molecular Subtypes of Breast Cancer

蛋白酶体活性和池异质性与确定乳腺癌分子亚型的标志物的关联

Irina Kondakova, Elena Sereda, Evgeniya Sidenko, Sergey Vtorushin, Valeria Vedernikova, Alexander Burov, Pavel Spirin, Vladimir Prassolov, Timofey Lebedev, Alexey Morozov, Vadim Karpov

Emetine in Combination with Chloroquine Induces Oncolytic Potential of HIV-1-Based Lentiviral Particles

依米丁与氯喹联合使用可诱导 HIV-1 慢病毒颗粒的溶瘤潜力

Pavel Spirin, Elena Shyrokova, Valeria Vedernikova, Timofey Lebedev, Vladimir Prassolov

PRMT1 is an important factor for medulloblastoma cell proliferation and survival

PRMT1 是髓母细胞瘤细胞增殖和存活的重要因素

Xiao Gu, Miao He, Timofey Lebedev, Cheng-Han Lin, Zhong-Yan Hua, Y George Zheng, Zhi-Jie Li, Jer-Yen Yang, Xing-Guo Li

Subtype of Neuroblastoma Cells with High KIT Expression Are Dependent on KIT and Its Knockdown Induces Compensatory Activation of Pro-Survival Signaling

具有高 KIT 表达的神经母细胞瘤细胞亚型依赖于 KIT,并且 KIT 的敲低会诱导促生存信号的补偿性激活

Timofey Lebedev, Anton Buzdin, Elmira Khabusheva, Pavel Spirin, Maria Suntsova, Maxim Sorokin, Vladimir Popenko, Petr Rubtsov, Vladimir Prassolov

Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes

生长因子信号预测治疗抵抗机制并定义神经母细胞瘤亚型

Timofey Lebedev, Elmira Vagapova, Pavel Spirin, Petr Rubtsov, Olga Astashkova, Alesya Mikheeva, Maxim Sorokin, Uliana Vladimirova, Maria Suntsova, Dmitry Konovalov, Alexander Roumiantsev, Carol Stocking, Anton Buzdin, Vladimir Prassolov

Cytotoxic Marine Alkaloid 3,10-Dibromofascaplysin Induces Apoptosis and Synergizes with Cytarabine Resulting in Leukemia Cell Death

细胞毒性海洋生物碱 3,10-二溴法斯卡林诱导细胞凋亡并与阿糖胞苷协同作用导致白血病细胞死亡

Pavel Spirin, Elena Shyrokova, Timofey Lebedev, Elmira Vagapova, Polina Smirnova, Alexey Kantemirov, Sergey A Dyshlovoy, Gunhild von Amsberg, Maxim Zhidkov, Vladimir Prassolov

Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs

选择性抑制 HDAC I 类可增强白血病和神经母细胞瘤细胞对抗癌药物的敏感性

Elmira Vagapova, Maxim Kozlov, Timofey Lebedev, Karina Ivanenko, Olga Leonova, Vladimir Popenko, Pavel Spirin, Sergey Kochetkov, Vladimir Prassolov

Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors

奥利多宁和 MAPK1/ERK2 抑制剂联合使用可协同抑制 t(8;21) 阳性白血病细胞生长

Pavel Spirin #, Timofey Lebedev #, Natalia Orlova #, Alexey Morozov, Nadezhda Poymenova, Sergey E Dmitriev, Anton Buzdin, Carol Stocking, Olga Kovalchuk, Vladimir Prassolov